← Open Payments lookup

ROBERT HUSEMANN: Open Payments

NPI 1013639749 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$803 in 53 payments from 14 companies in 2025. Trend: 2023 $793 · 2024 $1,303 · 2025 $803

Food & beverage: $803
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$191
ABBVIE INC.5$100
Otsuka America Pharmaceutical, Inc.5$100
Teva Pharmaceuticals USA, Inc.4$73
Alkermes, Inc.4$72
Supernus Pharmaceuticals, Inc.3$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Lundbeck LLC2$37
HARMONY BIOSCIENCES LLC1$21
Collegium Pharmaceutical, Inc.1$21

Products named: INGREZZA, VRAYLAR, REXULTI, ARISTADA, Qelbree, CAPLYTA, AUSTEDO XR, UZEDY.

Industry payments across IA — which companies pay providers there.